Accession Number : ADA558397


Title :   Medical Surveillance Monthly Report (MSMR). Volume 19, Number 3, March 2012


Descriptive Note : Monthly rept.


Corporate Author : ARMED FORCES HEALTH SURVEILLANCE CENTER SILVER SPRING MD


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/a558397.pdf


Report Date : Mar 2012


Pagination or Media Count : 25


Abstract : After a 12-year hiatus, military recruit training centers resumed administration of adenovirus type 4 and type 7 vaccine, live, oral (adenovirus vaccine) to trainees beginning in October of 2011. Subsequently, rates of febrile respiratory illnesses (FRI) and adenovirus isolations markedly declined. These findings are consistent with those of a placebo-controlled efficacy trial conducted prior to the vaccine s licensure by the U.S. Food and Drug Administration. Continued surveillance will clarify the longer term impact of vaccine use.


Descriptors :   *ADENOVIRUSES , *VACCINES , ACTIVE DUTY , MENTAL HEALTH , MILITARY FORCES(UNITED STATES) , MILITARY PERSONNEL , ORAL INTAKE , PLACEBOS , RECRUITS , RESPIRATORY DISEASES , SCHIZOPHRENIA , THORAX , TRAINEES , VARIOLA VIRUS


Subject Categories : Microbiology


Distribution Statement : APPROVED FOR PUBLIC RELEASE